Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

310 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Endogenous glutamine production in critically ill patients: the effect of exogenous glutamine supplementation.
Mori M, Rooyackers O, Smedberg M, Tjäder I, Norberg A, Wernerman J. Mori M, et al. Among authors: wernerman j. Crit Care. 2014 Apr 14;18(2):R72. doi: 10.1186/cc13829. Crit Care. 2014. PMID: 24731231 Free PMC article. Clinical Trial.
Availability of amino acids supplied intravenously in healthy man as synthetic dipeptides: kinetic evaluation of L-alanyl-L-glutamine and glycyl-L-tyrosine.
Albers S, Wernerman J, Stehle P, Vinnars E, Fürst P. Albers S, et al. Among authors: wernerman j. Clin Sci (Lond). 1988 Nov;75(5):463-8. doi: 10.1042/cs0750463. Clin Sci (Lond). 1988. PMID: 3254762 Clinical Trial.
Clinical experiences with glutamine supplementation.
Wernerman J, Hammarqvist F. Wernerman J, et al. Nutrition. 1994 Mar-Apr;10(2):176-7. Nutrition. 1994. PMID: 8025373 No abstract available.
A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes.
Gamrin L, Essén P, Forsberg AM, Hultman E, Wernerman J. Gamrin L, et al. Among authors: wernerman j. Crit Care Med. 1996 Apr;24(4):575-83. doi: 10.1097/00003246-199604000-00005. Crit Care Med. 1996. PMID: 8612406
Skeletal muscle glutathione is depleted in critically ill patients.
Hammarqvist F, Luo JL, Cotgreave IA, Andersson K, Wernerman J. Hammarqvist F, et al. Among authors: wernerman j. Crit Care Med. 1997 Jan;25(1):78-84. doi: 10.1097/00003246-199701000-00016. Crit Care Med. 1997. PMID: 8989180
Tissue protein synthesis rates in critically ill patients.
Essén P, McNurlan MA, Gamrin L, Hunter K, Calder G, Garlick PJ, Wernerman J. Essén P, et al. Among authors: wernerman j. Crit Care Med. 1998 Jan;26(1):92-100. doi: 10.1097/00003246-199801000-00022. Crit Care Med. 1998. PMID: 9428549
Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients.
Gamrin L, Essén P, Hultman E, McNurlan MA, Garlick PJ, Wernerman J. Gamrin L, et al. Among authors: wernerman j. Ann Surg. 2000 Apr;231(4):577-86. doi: 10.1097/00000658-200004000-00018. Ann Surg. 2000. PMID: 10749620 Free PMC article. Clinical Trial.
Growth hormone does not affect albumin synthesis in the critically ill.
Barle H, Gamrin L, Essén P, McNurlan MA, Garlick PJ, Wernerman J. Barle H, et al. Among authors: wernerman j. Intensive Care Med. 2001 May;27(5):836-43. doi: 10.1007/s001340100914. Intensive Care Med. 2001. PMID: 11430539 Free PMC article. Clinical Trial.
The local vascular tolerance to an intravenous infusion of a concentrated glutamine solution in ICU patients.
Berg A, Forsberg E, Wernerman J. Berg A, et al. Among authors: wernerman j. Clin Nutr. 2002 Apr;21(2):135-9. doi: 10.1054/clnu.2001.0520. Clin Nutr. 2002. PMID: 12056785 Clinical Trial.
Longitudinal pattern of glutamine/glutamate balance across the leg in long-stay intensive care unit patients.
Vesali RF, Klaude M, Rooyackers OE, TJäder I, Barle H, Wernerman J. Vesali RF, et al. Among authors: wernerman j. Clin Nutr. 2002 Dec;21(6):505-14. doi: 10.1054/clnu.2002.0583. Clin Nutr. 2002. PMID: 12468371
310 results
Jump to page
Feedback